Johnson & Johnson (JNJ) EBT Margin (2009 - 2026)

Johnson & Johnson has disclosed EBT Margin across 18 years of filings, most recently posting 26.66% for Q2 2026.

• In Q2 2026, EBT Margin fell 68.0% year-over-year to 26.66%; the TTM figure through Jun 2026 stood at 25.73% (down 445.0% YoY), while the FY2025 annual figure was 34.59%, up 1580.0% from the prior year.
• EBT Margin came in at 26.66% for Q2 2026 at Johnson & Johnson, up from 24.89% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 62.26% in Q1 2025 to a low of 6.16% in Q2 2023.
• Average EBT Margin over 5 years is 24.15%, with a median of 25.17% recorded in 2022.
• Year-over-year, EBT Margin jumped 4489 bps in 2025 and sank 3737 bps in 2026.
• Over 5 years, EBT Margin stood at 25.87% in 2022, then declined by 13 bps to 22.56% in 2023, then slipped by 23 bps to 17.26% in 2024, then rose by 17 bps to 20.22% in 2025, then surged by 32 bps to 26.66% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 26.66% in Q2 2026, 24.89% in Q1 2026, and 20.22% in Q4 2025.